Form 4: Windsor Private Capital Reduces AIFF Stake

Windsor Private Capital LP and affiliated entities, including directors, reported the sale of 102,675 shares of Firefly Neuroscience, Inc. common stock in mid-October 2025.

Summary

• Windsor Private Capital LP, along with affiliated entities and individuals, reported the sale of 102,675 shares of Firefly Neuroscience, Inc. (AIFF) common stock.
• The sales occurred over three consecutive days: October 15, 16, and 17, 2025.
• These transactions were executed as broker-dealer sales under Rule 144 and pursuant to a Rule 10b5-1(c) trading plan.
• Following these transactions, the reporting persons collectively beneficially own 1,367,526 shares of AIFF common stock indirectly through Windsor Private Capital LP.
• The reporting persons are identified as a 'group' that beneficially owns more than 10% of AIFF's common stock and include individuals who are directors of the issuer.

Sentiment

Score: 3

Explanation: The sale of a significant number of shares by a 10% owner and director group, even under a 10b5-1 plan, is generally perceived as a negative signal by the market, indicating a potential lack of confidence or a desire to diversify holdings away from the company.

Positives

• The sales were conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary trading plan, which can mitigate concerns about opportunistic insider selling.

Negatives

• Significant insider selling by a 10% owner and director group, totaling 102,675 shares, could be perceived as a negative signal regarding the company's near-term prospects or valuation.
• The average sale price decreased over the three days, from $2.7444 on October 15, 2025, to $2.5462 on October 17, 2025, suggesting a declining market price during the sale period.

Risks

• The insider selling by a significant shareholder and director group could be interpreted by the market as a signal of perceived risks by the reporting persons regarding the company's future performance or valuation.

Future Outlook

NA

Industry Context

NA

Management Changes

Related Party Transactions

• The reported sales of common stock by Windsor Private Capital LP and its affiliated reporting persons constitute related party transactions, as these entities and individuals are directors and a 10% owner of Firefly Neuroscience, Inc.

Stakeholder Impact

• Shareholders may interpret the insider selling as a bearish signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Potential investors might view the sales as a reason to reconsider investment in Firefly Neuroscience, Inc.

Key Dates

Recommendation

The sale of over 100,000 shares by a significant insider group, including directors and a 10% owner, signals a reduction in their stake in Firefly Neuroscience, Inc. While conducted under a 10b5-1 plan, such a substantial divestment by knowledgeable insiders often precedes periods of underperformance or reflects a belief that the stock is fully valued or overvalued. This action suggests a lack of strong conviction in the company's near-term growth prospects from a key stakeholder, warranting a 'sell' recommendation for investors to consider reducing their exposure.

Keywords

Firefly Neuroscience, AIFF, Windsor Private Capital, Insider Selling, Form 4, 10b5-1 Plan, Equity Sales, Director Transactions, 10% Owner